Kristin Andersen Selected Research

Kristin Andersen Research Topics

Disease

18	Neoplasms (Cancer) 05/2024 - 01/2003
5	Neoplasm Metastasis (Metastasis) 04/2011 - 01/2003
3	Breast Neoplasms (Breast Cancer) 01/2014 - 04/2011
3	Osteosarcoma (Osteogenic Sarcoma) 08/2004 - 01/2003
2	Abnormal Karyotype 04/2024 - 11/2023
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 07/2022
2	Leukemia 07/2023 - 01/2021
2	Genetic Translocation (Chromosomal Translocation) 03/2023 - 07/2022
2	Lipoma (Lipomata) 03/2023 - 03/2023
2	Carcinogenesis 01/2023 - 07/2022
2	Leiomyoma (Uterine Fibroids) 11/2022 - 07/2021
1	Angiomyoma (Angioleiomyoma) 11/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Myxoma (Myxomas) 09/2022
1	Microsatellite Instability 07/2022
1	Rhabdomyosarcoma 11/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Angiofibroma 09/2020
1	Solitary Fibrous Tumors 09/2020
1	Bone Cysts (Bone Cyst) 09/2020
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 09/2020
1	Pleomorphic Adenoma 05/2020
1	Osteoblastoma 09/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Ependymoma 12/2016
1	Melanoma (Melanoma, Malignant) 08/2004
1	Carcinoma (Carcinomatosis) 01/2003
1	Prostatic Neoplasms (Prostate Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

14	RNA (Ribonucleic Acid)IBA 11/2023 - 12/2016
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2003
3	Carrier Proteins (Binding Protein)IBA 03/2023 - 08/2004
2	Ubiquitin-Specific ProteasesIBA 05/2024 - 09/2020
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2024 - 11/2023
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2023 - 01/2019
2	Intergenic DNA (Junk DNA)IBA 11/2023 - 07/2022
2	MicroRNAs (MicroRNA)IBA 11/2022 - 07/2022
2	Interferon-gamma (Interferon, gamma)IBA 01/2007 - 08/2004
2	Tissue Inhibitor of Metalloproteinase-2IBA 12/2003 - 01/2003
2	Matrix Metalloproteinases (MMPs)IBA 12/2003 - 01/2003
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2024
1	Fibronectins (Fibronectin)IBA 05/2024
1	Codon (Codons)IBA 01/2024
1	Untranslated RNA (Noncoding RNA)IBA 11/2023
1	Notch ReceptorsIBA 11/2023
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 11/2023
1	Mediator ComplexIBA 11/2023
1	Insulin Receptor Substrate ProteinsIBA 11/2023
1	Tec protein-tyrosine kinaseIBA 11/2023
1	AntigensIBA 07/2023
1	Heterogeneous-Nuclear Ribonucleoprotein Group A-BIBA 03/2023
1	SyndecansIBA 03/2023
1	GelsolinIBA 03/2023
1	Complementary DNA (cDNA)IBA 01/2023
1	Terminator Codon (Termination Codon)IBA 01/2023
1	Histones (Histone)IBA 03/2022
1	Nuclear Receptor Co-Repressor 2IBA 03/2022
1	P 11 (P-11)IBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	myocardinIBA 11/2021
1	Topoisomerase II InhibitorsIBA 01/2021
1	Pyridinolcarbamate (P23)IBA 09/2020
1	LumicanIBA 09/2020
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2014
1	Epithelial Cell Adhesion MoleculeIBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 08/2011
1	Calcium-Binding ProteinsIBA 04/2011
1	S100 Calcium-Binding Protein A4IBA 04/2011
1	Indicators and Reagents (Reagents)IBA 04/2011
1	Catalytic RNA (Ribozymes)IBA 08/2004
1	Cadherins (E-Cadherin)IBA 08/2004
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 12/2003
1	Colchicine FDA LinkGeneric 12/2003
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2003
1	progelatinaseIBA 12/2003
1	Metalloproteases (Metalloproteinases)IBA 01/2003
1	AndrogensIBA 01/2003

Therapy/Procedure

3	Therapeutics 04/2021 - 12/2015